Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Comprehensive Income	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2021	$ 1	$ 96,420	$ 4	$ (81,828)	$ 14,597
Balance at beginning of period (shares) at Dec. 31, 2021	888,693
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		207			207
Foreign currency translation adjustment			(1)		(1)
Net loss				(2,875)	(2,875)
Balance at end of period at Mar. 31, 2022	$ 1	96,627	3	(84,703)	11,928
Balance at end of period (shares) at Mar. 31, 2022	888,693
Balance at beginning of period at Dec. 31, 2021	$ 1	96,420	4	(81,828)	14,597
Balance at beginning of period (shares) at Dec. 31, 2021	888,693
Increase (Decrease) in Stockholders' Equity
Net loss					(6,178)
Balance at end of period at Jun. 30, 2022	$ 1	96,838		(88,006)	8,833
Balance at end of period (shares) at Jun. 30, 2022	888,693
Balance at beginning of period at Mar. 31, 2022	$ 1	96,627	3	(84,703)	11,928
Balance at beginning of period (shares) at Mar. 31, 2022	888,693
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		211			211
Foreign currency translation adjustment			$ (3)		(3)
Net loss				(3,303)	(3,303)
Balance at end of period at Jun. 30, 2022	$ 1	96,838		(88,006)	8,833
Balance at end of period (shares) at Jun. 30, 2022	888,693
Balance at beginning of period at Dec. 31, 2022	$ 25	117,520		(95,795)	21,750
Balance at beginning of period (shares) at Dec. 31, 2022	25,436,019
Increase (Decrease) in Stockholders' Equity
Issuance of stock from exercise of warrants	$ 2	1,434			1,436
Issuance of stock from exercise of warrants (in shares)	1,740,666
Stock-based compensation		(74)			(74)
Net loss				(2,604)	(2,604)
Balance at end of period at Mar. 31, 2023	$ 27	118,880		(98,399)	20,508
Balance at end of period (shares) at Mar. 31, 2023	27,176,685
Balance at beginning of period at Dec. 31, 2022	$ 25	117,520		(95,795)	21,750
Balance at beginning of period (shares) at Dec. 31, 2022	25,436,019
Increase (Decrease) in Stockholders' Equity
Issuance of stock from exercise of warrants					6,833
Net loss					(3,338)
Balance at end of period at Jun. 30, 2023	$ 38	124,291		(99,133)	25,196
Balance at end of period (shares) at Jun. 30, 2023	38,241,685
Balance at beginning of period at Mar. 31, 2023	$ 27	118,880		(98,399)	20,508
Balance at beginning of period (shares) at Mar. 31, 2023	27,176,685
Increase (Decrease) in Stockholders' Equity
Issuance of stock from exercise of warrants	$ 11	5,387			5,398
Issuance of stock from exercise of warrants (in shares)	11,065,000
Stock-based compensation		24			24
Net loss				(734)	(734)
Balance at end of period at Jun. 30, 2023	$ 38	$ 124,291		$ (99,133)	$ 25,196
Balance at end of period (shares) at Jun. 30, 2023	38,241,685